Abstract
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide with potent neurotrophic and neuroprotective effects. We have previously shown that PACAP protects against several types of retinal injuries in vivo, including retinal ischemia, glutamate-induced excitotoxicity, UV A-induced lesion, and diabetic retinopathy. We have also shown that PACAP activates antiapoptotic pathways and inhibits proapoptotic signaling in retinal lesions in vivo. PACAP receptors have been identified on the retinal pigment epithelial cells and PACAP has been shown to inhibit interleukin secretion from pigment epithelial cells. It is not known, however, whether PACAP is protective in these cells. Human retinal pigment epithelial cells (ARPE-19 cell line) were exposed to in vitro oxidative stress by hydrogen peroxide. Cell survival was decreased in cells exposed to oxidative stress, which could be significantly and dose-dependently attenuated by 10 pM–1 μM PACAP treatment, as shown by MTT viability test. The protective effect of PACAP could be blocked by the receptor antagonist PACAP6-38. In addition, flow cytometry and JC-1 assay revealed that oxidative stress-induced apoptosis in retinal pigment epithelial cells could be decreased by PACAP treatment. In summary, these results show, for the first time, that PACAP is antiapoptotic in the retinal pigment epithelial cells.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The biological actions of pituitary adenylate cyclase-activating polypeptide (PACAP) are very diverse. Among others, the neuropeptide influences reproductive functions, circadian rhythm, thermoregulation, feeding, depression, memory, urinary reflexes, inflammatory reactions, and development (Falluel-Morel et al. 2008; Girard et al. 2008; Hagino 2008; Monaghan et al. 2008; Nagy and Csernus 2007; Racz et al. 2008b; Reichenstein et al. 2008; Vaudry et al. 2009; Yoshiyama and de Groat 2008). PACAP has well-established neurotrophic and neuroprotective functions (Deguil et al. 2010; Dejda et al. 2008; Ohtaki et al. 2008; Scharf et al. 2008; Somogyvari-Vigh and Reglodi 2004; Vaudry et al. 2009). These effects have been proven also in the retina (Atlasz et al. 2010b). In vitro, PACAP is protective against glutamate toxicity in retinal neurons (Shoge et al. 1999). In retinal explants, PACAP has been shown to be protective against thapsigargin-induced photoreceptor cell death and anisomycin-induced cell death in the neuroblastic layer (Silveira et al. 2002). PACAP-treated turtle eyecup preparations show electrical activity for a significantly longer time (Rabl et al. 2002). In vivo, PACAP has been shown to be protective against optic nerve transection, glutamate- and kainate-induced excitotoxic injury, and ischemic degeneration (Atlasz et al. 2007, 2009, 2010b; Babai et al. 2005; Racz et al. 2007a; Seki et al. 2006, 2008). We found that the protective effects of PACAP are not neuronal phenotype-specific but rather reflect the stimulation of a common protective pathway found in all examined neuronal cell types (Atlasz et al. 2008, 2010a).
Most studies on retinoprotective strategies focus on the retinal layers derived from the inner layer of the optic cup (Mester et al. 2009; Rojas et al. 2009; Szabadfi et al. 2009), since these layers contain the neurons arranged in three vertical layers. However, the outermost layer of the retina, the pigment epithelial cell layer, is also a very important part of the retina. The integrity of the pigment epithelial cells is critical for the photoreceptor survival and vision (Bazan 2006, 2008). Photoreceptor degeneration involves the closely associated retinal pigment epithelial cells in several ocular diseases, including age-related macular degeneration (Bazan 2006; Kook et al. 2008).
Oxidative stress is one of the most common apoptosis-inducing factors in several organs from the intestinal and cardiovascular systems to neuronal cells, including the extremely vulnerable sensory organs (Ferencz et al. 2002; Racz et al. 2007b, 2010; Vaudry et al. 2002). Not surprisingly, oxidative stress-induced apoptosis has been shown to play a role also in pigment epithelial cell death (Kalariya et al. 2008; Kook et al. 2008). Human pigment epithelial cells possess PAC1 and VPAC receptors, as shown by PCR studies (Zhang et al. 2005). Vasoactive intestinal peptide, a peptide related to PACAP, has been shown to have effects on pigment epithelial cells: it induces cAMP formation (Koh and Chader 1984), influences proliferation (Kishi et al. 1996; Troger et al. 2003) and induces differentiation of retinal pigment cells from mesenchymal cells (Vossmerbaeumer et al. 2009). A previous study has shown that PACAP inhibited the interleukin 1β-stimulated expression of interleukin-6 and -8 and monocyte chemotactic protein-1 in ARPE-19 human pigment epithelial cells (Zhang et al. 2005). In spite of the numerous studies showing the protective effects of PACAP in the retina, no data are currently available on the potential protective effect of PACAP against oxidative stress in pigment epithelial cells. Therefore, it seemed reasonable to study whether PACAP is able to increase cell survival in oxidative stress-induced apoptosis of human pigment epithelial cells.
Materials and Methods
Cell Culture
ARPE-19 is an immortalized cell line of human retinal pigment epithelium (RPE) that is used widely to draw inferences about the behavior of adult human RPE (ahRPE) (Cai and Del Priore 2006). Cells were obtained from American Type Culture Collection (Manassas, VA, USA). These cells were cultured in DMEM/Ham’s F12 supplemented with 10% FCS, penicillin (100 U/mL), and streptomycin sulfate (100 μg/mL). The cells were grown at 37°C in a humidified 5% CO2 atmosphere.
Cell Viability Test
ARPE-19 (1.5 × 104/well) cells were seeded in 96-well microculture plate and cultured overnight before treatment with increasing concentration of H2O2 (0.2 to 0.3 mM) and 10 nM PACAP1-38. Untreated control cells were handled in a similar fashion without H2O2. In order to test whether the action of PACAP is specific, separate groups of 0.25 mM H2O2-treated cells were incubated with 1 μM PACAP6-38 alone or together with 10 nM PACAP1-38. After the first set of experiments proving the protective effects of PACAP, we tested the dose dependency of PACAP treatment on the viability of ARPE-19 cells. Cells were exposed to 0.25 mM H2O2 in the presence of 1 pM to 1 μM PACAP1-38. Furthermore, the experiment was repeated in the presence of inhibitors of different signaling pathways. The inhibitors used were 10 μM PD 98059 (ERK inhibitor), 2 μM SB 203580 (p38 inhibitor), 5 μM JNK Inhibitor II and 10 μM Ly 294002 (Akt inhibitor).
Viability of cells was determined by the addition of MTT solution (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, Sigma, Hungary) at a 1:10 volume ratio for 4 h at 37°C, according to the manufacturer’s instruction (Sigma, Hungary). The assay is based on the reduction of MTT into a blue formazan dye by the functional mitochondria of viable cells. Samples from duplicate wells were transferred to a 96-well plate and absorbance was measured by an ELISA reader (Anthos Labtech 2010, Austria) at 550 nm, representing the values in arbitrary unit. Results are expressed as percentage of control values. Statistical analysis was performed by ANOVA test and results were considered significant at p < 0.05.
Annexin V and Propidium Iodide Staining of the Cells
Ratio of apoptosis was evaluated after double-staining with fluorescein isothiocyanate (FITC)-labeled annexin V (BD Biosciences, Hungary) and propidium iodide (PI) (BD Biosciences, Hungary) using flow cytometry (FacsCalibur, BD Biosciences, USA). First, the medium was discarded and the wells were washed twice with isotonic NaCl solution. Cells were removed from the plates using a mixture of 0.25% trypsin (Sigma, Hungary), 0.2% ethylene-diamin tetra-acetate (Serva, Hungary), 0.296% sodium citrate, and 0.6% sodium chloride in distilled water for 15 min at 37°C. Removed cells were washed twice in cold phosphate-buffered saline and were resuspended in binding buffer containing 10 mM Hepes NaOH, pH 7.4, 140 mM NaCl and 2.5 mM CaCl2. Cell count was determined in Burker’s chamber for achieving a dilution in which 1 ml of solution contains 106 cells. One hundred microliters of buffer (105 cells) was transferred into 5-ml round-bottom polystyrene tubes. Cells were incubated for 15 min with fluorescein isothiocyanate-conjugated annexin V molecules and PI. After this period of incubation, 400 μl of annexin-binding buffer (BD Biosciences, Hungary) was added to the tubes as described by the manufacturers. The samples were immediately measured by BD FacsCalibur flow cytometer (BD Biosciences, USA).
Results were analyzed by Cellquest software (BD Biosciences, USA). Quadrant dot plot was introduced to identify living and necrotic cells and cells in early or late phase of apoptosis. Living cells were identified as annexin V-FITC and PI-negative. Apoptotic cells were branded as annexin V-FITC-positive only and cells in late apoptosis were recognized as double-positive for annexin V-FITC and PI. Cells in each category were expressed as the percentage of the total number of stained cells counted.
JC-1 Assay for Flow Cytometry
JC-1 assay kit for flow cytometry was used to detect apoptosis in cultured cells (Invitrogen, Molecular Probes, Hungary). Cells were incubated with 10 μl of 200 μM JC-1 (2 μM final concentration) for 30 min. Cells were washed once by adding 2 ml of warm PBS to each tube of cells. The cells were pelleted by centrifugation. Cells were resuspended by gently flicking the tubes and 500 μl PBS was added to each tube. The samples were immediately measured by BD FacsCalibur flow cytometer (BD Biosciences, USA). The red/green fluorescence ratio was introduced to identify living and apoptotic cells. JC-1 exhibits potential-dependent accumulation in mitochondria, indicated by a fluorescence emission shift from green (≈529 nm) to red (≈590 nm). Consequently, mitochondrial depolarization is indicated by a decrease in the red/green fluorescence intensity ratio. Cells in each category were expressed as the percentage of the total number of stained cells counted. Results were analyzed by Cellquest software (BD Biosciences, USA).
Results
Initial experiments were performed to assess the rate of cell viability loss on exposure of the cells to oxidative stress. Cells were treated with various doses of H2O2 for 3 h, and cell viability was determined with MTT assay. Similarly to findings by others, ARPE-19 cells were resistant to low concentrations of H2O2 but rapidly lost viability with an increase in H2O2 concentration (Qin et al. 2006). Exposure of the cells to 0.25 mM H2O2 for 3 h reduced viable cells to approximately 50% of control. Therefore, we chose this concentration for our further experiments. PACAP1-38 or PACAP6-38 administration alone caused no changes in cell viability. Treatment with 10 nM PACAP for 3 h significantly increased the percentage of viable cells after exposure to oxidative injury, which could be blocked by PACAP6-38 co-application (Fig. 1a). Furthermore, we showed that this effect was dose dependent: 1 pM PACAP1-38 did not lead to a significant increase in cell survival; 10 and 100 pM could significantly decrease the effect of oxidative stress. Best result was achieved by 100 nM PACAP1-38 treatment (Fig. 1b). We repeated the experiments with 10 nM PACAP in the presence of various inhibitors of the MAPK and PI3K/Akt pathways. It was found that the co-application of different MAPK inhibitors did not influence the protective effect of PACAP, while the presence of PI3K/Akt inhibitor significantly reduced this protective effect (data not shown).
Annexin V and propidium iodide staining were used to detect apoptosis and necrosis in cultured cells. In the late phase of apoptosis, cells are stained with both dyes. Using this method, we found that the control group had more than 96% of intact, living cells and only less than 4% of cells in the necrotic and early, late phases of apoptosis (Figs. 2 and 3). An increase of apoptotic and necrotic cells was observed in the H2O2-treated group with a lower number of living cells. PACAP administration alone caused no changes in the percentage of living, necrotic, and apoptotic cells compared to control values. Necrosis was slightly decreased upon PACAP treatment, but differences were not statistically significant. However, PACAP administration led to a significant increase in the percentage of living cells and a reproducible decrease in the rate of apoptosis (Figs. 2 and 3).
JC-1 is for the detection of mitochondrial depolarization occurring in apoptosis. Using the JC-1 assay for flow cytometry, we found that the control group and the group treated with PACAP alone had more than 98% of living cells (Figs. 4 and 5). An increase of apoptotic cell number was observed in the H2O2-treated group with a lower number of living cells. PACAP administration led to a significant increase in the percentage of living cells and a decrease in the percentage of apoptotic cells exposed to H2O2 (Figs. 4 and 5).
Discussion
The present study shows that PACAP is able to exert protective actions against oxidative stress in human retinal pigment epithelial cells. In addition to the numerous studies providing evidence for the protective effects of PACAP in the neuronal retina, this is the first study that demonstrates such effects in the pigment epithelial cells.
PACAP receptors have been identified earlier in several neuronal layers of the retina. The selective PACAP receptors are responsible for approximately 80% of PACAP binding in the retina (Nilsson et al. 1994). Radioligand binding studies have revealed the existence of PACAP receptors also in the human fetal retina and in retinoblastoma cells (Olianas et al. 1996, 1997). Detailed localization studies have revealed a strong expression of PAC1 receptor mRNA in the ganglion cell layer, inner nuclear layer, and nerve fiber layer, while a weaker expression in the inner and outer plexiform and the outer nuclear layers and the outer segments of the photoreceptors was observed (Seki et al. 1997, 2000). In culture, PAC1 receptor expression has been shown in the Muller glial cells, where PACAP exerts several functions (Kubrusly et al. 2005; Nakatani et al. 2006). In retinal pigment epithelial cells, PAC1 and VPAC1 receptors have been identified by RT-PCR studies (Zhang et al. 2005). The same study has shown that PACAP inhibited the interleukin 1β-stimulated expression of interleukin-6 and -8 and monocyte chemotactic protein-1 (Zhang et al. 2005). The authors used the same human pigment epithelial cell line (ARPE-19) that we used also in our present study.
Pigment epithelial cells perform a wide variety of functions that are critical during the embryonic development of the retina as well as throughout adult life to maintain normal vision (Grunwald 2009). Originally, the pigment layer of the retina was thought to function mainly as an absorptive layer of stray light to enhance visual acuity. However, these cells play several other important roles, such as formation of the blood–retinal barrier, elimination of waste products, selective transport to photoreceptors, processing of vitamin A in the visual cycle and phagocytosis of the photoreceptor outer segments disks facilitating the renewal of the photoreceptors. By building a barrier between blood and photoreceptors and by possessing specialized apical, basal, and lateral surfaces, pigment epithelial cells also provide a protective layer against toxic and oxidative damage that would be harmful for the photoreceptors. However, the retinal pigment epithelium itself is constantly exposed to external injuries, including oxidative stress. This may lead to degeneration, dysfunction, or loss of pigment epithelial cells. The balance between RPE cell death and proliferation may be responsible for several diseases of the underlying retina (Roduit and Schorderet 2008). High oxygen tension, exposure to light and the biochemical events of vision generate significant oxidative stress in the retina and the retinal pigment epithelium (Maeda et al. 2005). Retinal pigment epithelial cells have been implicated in several retinal diseases, including age-related macular degeneration, which is the leading cause of blindness among adults in developed countries, and in proliferative vitreoretinopathy, which is a major complication resulting from retinal detachment (Grunwald 2009).
Our results indicate that PACAP has antiapoptotic effects in oxidative stress-induced cell death in retinal pigment epithelial cells. This is in accordance with other studies showing that PACAP protects cells of different origin against oxidative stress. Not only neuronal cells but also non-neuronal cells have been demonstrated to react with decreased apoptotic rate when exposed to PACAP. Such effects have been described in cerebellar granule cells (Vaudry et al. 2002), cochlear cell culture (Racz et al. 2010), endothelial cells (Racz et al. 2007b) and cardiomyocytes (Gasz et al. 2006; Racz et al. 2008a). The exact mechanism of the observed protective effect is not known at the moment, but our results indicate the involvement of the Akt signaling pathway, since the survival-promoting effect of PACAP was significantly reduced in the presence of the PI3K/Akt inhibitor. This is in agreement with previous observations showing the involvement of the Akt signaling pathway in the protective effects of PACAP (Racz et al. 2007a, 2008a).
Based on our present results, it can be hypothesized that such an effect is also present endogenously. Numerous studies have shown that PACAP-deficient mice react to damaging insults with increased susceptibility. For example, cerebellar granule cells isolated from PACAP knockout mice react to oxidative stress with a higher apoptotic rate (Vaudry et al. 2005). In addition, PACAP-deficient mice have increased neuronal damage in brain ischemia (Ohtaki et al. 2008) and axonal regeneration is delayed in a model of axotomy (Armstrong et al. 2008). Recently, we have shown that even kidney tubular cells isolated from PACAP-deficient mice are more sensitive to oxidative stress (Horvath et al. 2010). Retinal pigment epithelial cells possess PACAP receptors, and an earlier study has revealed that PACAP inhibits some inflammatory cytokine expression in these cells (Zhang et al. 2005). It is possible that PACAP is a survival-promoting factor also in retinal pigment epithelial cells.
In summary, our present results show that PACAP has antiapoptotic effects against oxidative stress-induced cell death in retinal human pigment epithelial cells, providing an additional piece of evidence for the retinoprotective effects of PACAP.
References
Armstrong BD, Abad C, Chhith S et al (2008) Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience 151:63–73
Atlasz T, Babai N, Kiss P et al (2007) Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in rats. Gen Comp Endocrinol 153:108–114
Atlasz T, Szabadfi K, Kiss P et al (2008) PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration. J Mol Neurosci 36:97–104
Atlasz T, Szabadfi K, Reglodi D et al (2009) Effects of pituitary adenylate cyclase activating polypeptide (PACAP1-38) and its fragments on retinal degeneration induced by neonatal MSG treatment. Ann NY Acad Sci 1163:348–352
Atlasz T, Szabadfi K, Kiss P et al (2010a) Evaluation of the protective effects of PACAP with cell-specific markers in ischemia-induced retinal degeneration. Brain Res Bull 81:497–504
Atlasz T, Szabadfi K, Kiss P et al (2010b) Review of pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Ann N Y Acad Sci 1200:128–139
Babai N, Atlasz T, Tamas A, Reglodi D, Kiss P, Gabriel R (2005) Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retina degeneration. Neurotox Res 8:227–233
Bazan NG (2006) Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci 29:263–271
Bazan NG (2008) Neurotrophins induce neuroprotective signaling in the retinal pigment epithelial cell by activating the synthesis of the anti-inflammatory and anti-apoptotic neuroprotectin D1. Adv Exp Med Biol 613:39–44
Cai H, Del Priore LV (2006) Gene expression profile of cultured adult compared to immortalized human RPE. Mol Vis 12:1–14
Deguil J, Chavant F, Lafay-Chebassier C, Perault-Pochat MC, Fauconneau B, Pain S (2010) Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice. Neurotox Res 17:142–155
Dejda A, Jolivel V, Bourgault S et al (2008) Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J Mol Neurosci 36:26–37
Falluel-Morel A, Aubert N, Vaudry D et al (2008) Interactions of PACAP and ceramides in the control of granule cell apoptosis during cerebellar development. J Mol Neurosci 36:8–15
Ferencz A, Szanto Z, Borsiczky B et al (2002) The effects of preconditioning on the oxidative stress in small-bowel autotransplantation. Surgery 132:877–884
Gasz B, Racz B, Roth E et al (2006) Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis. Peptides 27:87–94
Girard BM, Wolf-Johnston A, Braas KM, Birder LA, May V, Vizzard MA (2008) PACAP-mediated ATP release from rat urothelium and regulation of PACAP/VIP and receptor mRNA in micturition pathways after cyclophosphamide (CYP)-induced cystitis. J Mol Neurosci 36:310–320
Grunwald GB (2009) Structure and function of the retinal pigment epithelium. In: Duane’s ophthalmology, chapter 21 (ed). Lippincott Williams & Wilkins, Philadelphia
Hagino N (2008) Performance of PAC1-R heterozygous mice in memory tasks—II. J Mol Neurosci 36:208–219
Horvath G, Mark L, Brubel R et al (2010) Mice dificient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro. Neurosci Lett 469:70–74
Kalariya NM, Ramana KV, Srivastava SK, van Kuijk FJ (2008) Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells. Exp Eye Res 86:70–80
Kishi H, Michima HK, Sakamoto I, Yamashita U (1996) Stimulation of retinal pigment epithelial cell growth by neuropeptides in vitro. Curr Eye Res 15:708–713
Koh SW, Chader GJ (1984) Agonist effect on the intracellular cyclic AMP concentration of retinal pigment epithelial cells in culture. J Neurochem 42:287–289
Kook D, Wolf AH, Yu AL et al (2008) The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci 49:1712–1720
Kubrusly RC, da Cunha MC, Reis RA et al (2005) Expression of functional receptors and transmitter enzymes in cultured Muller cells. Brain Res 1038:141–149
Maeda A, Crabb JW, Palczewski K (2005) Microsomal glutathione S-transferase 1 in the retinal pigment epithelium: protection against oxidative stress and a potential role in aging. Biochemistry 44:480–489
Mester L, Szabo A, Atlasz T et al (2009) Protection against chronic hypoperfusion-induced retinal neurodegeneration by PARP inhibition via activation of PI3-kinase Akt pathway and suppression of JNK and p38 MAP kinases. Neurotox Res 18:68–76
Monaghan TK, Pou C, MacKenzie CJ, Plevin R, Lutz EM (2008) Neurotrophic actions of PACAP-38 and LIF on human neuroblastoma SH-SY5Y cells. J Mol Neurosci 36:45–56
Nagy AD, Csernus VJ (2007) The role of PACAP in the control of circadian expression of clock genes in the chicken pineal gland. Peptides 28:1767–1774
Nakatani M, Seki T, Shinohara Y et al (2006) Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates production of interleukin-6 in rat Muller cells. Peptides 27:1871–1876
Nilsson SF, De Neef P, Robberecht P, Christophe J (1994) Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase. Exp Eye Res 58:459–467
Ohtaki H, Nakamachi HT, Dohi K, Shioda S (2008) Role of PACAP in ischemic neural death. J Mol Neurosci 36:16–25
Olianas MC, Ennas MG, Lampis G, Onali P (1996) Presence of pituitary adenylate cyclase activating polypeptide in Y-79 human retinoblastoma cells. J Neurochem 67:1293–1300
Olianas MC, Ingianni A, Sogos V, Onali P (1997) Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors and PACAP in human fetal retina. J Neurochem 69:1213–1218
Qin S, McLaughlin AP, De Vries GW (2006) Protection of RPE cells from oxidative injury by 15-deoxy-Δ12,14-prostaglandin J2 by augmenting GSH and activating MAPK. Invest Ophthalmol Vis Sci 47:5098–5105
Rabl K, Reglodi D, Banvolgyi T et al (2002) PACAP inhibits anoxia-induced changes in physiological responses in horizontal cells in the turtle retina. Regul Pept 109:71–74
Racz B, Gallyas F Jr, Kiss P et al (2007a) Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-Bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal rats. Neurotox Res 12:95–104
Racz B, Gasz B, Borsiczky B et al (2007b) Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis. Gen Comp Endocrinol 153:115–123
Racz B, Gasz B, Gallyas F Jr et al (2008a) PKA-Bad-14-3-3 and Akt-Bad-14-3-3 signaling pathways are involved in the protective effects of PACAP against ischemia/reperfusion-induced cardiomyocyte apoptosis. Regul Pept 145:105–115
Racz B, Horvath G, Faluhelyi N et al (2008b) Effects of PACAP on the circadian changes of signaling pathways in chicken pinealocytes. J Mol Neurosci 36:220–226
Racz B, Horvath G, Reglodi D et al (2010) PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study. Regul Pept 160:91–98
Reichenstein M, Rehavi M, Pinhasov A (2008) Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action. J Mol Neurosci 36:330–338
Roduit R, Schorderet DF (2008) MAP kinase pathways in UV-induced apoptosis of retinal pigment epithelium ARPE19 cells. Apoptosis 13:343–353
Rojas JC, John JM, Lee J, Gonzalez-Lima F (2009) Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy. Neurotox Res 15:260–273
Scharf E, May V, Braas KM, Shutz KC, Mao-Draayer Y (2008) Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) regulate murine neural progenitor cell survival, proliferation, and differentiation. J Mol Neurosci 36:79–88
Seki T, Shioda S, Ogino D, Nakai Y, Arimura A, Koide R (1997) Distribution and ultrastructural localization of a receptor for pituitary adenylate cyclase activating polypeptide and its mRNA in the rat retina. Neurosci Lett 238:127–130
Seki T, Izumi S, Shioda S, Zhou CJ, Arimura A, Koide R (2000) Gene expression for PACAP receptor mRNA in the rat retina by in situ hybridization and in situ RT-PCR. Ann NY Acad Sci 921:366–369
Seki T, Nakatani N, Taki C et al (2006) Neuroprotective effects of PACAP against kainic acid-induced neurotoxicity in rat retina. Ann NY Acad Sci 1070:531–534
Seki T, Itoh H, Nakamachi T, Shioda S (2008) Suppression of ganglion cell death by PACAP following optic nerve transection in the rat. J Mol Neurosci 36:57–60
Shoge K, Mishima HK, Saitoh T et al (1999) Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons. Brain Res 839:66–73
Silveira MS, Costa MR, Bozza M, Linden R (2002) Pituitary adenylate cyclase activating polypeptide prevents induced cell death in retinal tissue through activation of cyclic AMP-dependent protein kinase. J Biol Chem 277:16075–16080
Somogyvari-Vigh A, Reglodi D (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide—review. Curr Pharm Des 10:2861–2889
Szabadfi K, Atlasz T, Reglodi D et al (2009) Urocortin 2 protects against retinal degeneration following bilateral common carotid artery occlusion in the rat. Neurosci Lett 455:42–45
Troger J, Sellemond S, Kieselbach G et al (2003) Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells. Br J Ophthalmol 87:1403–1408
Vaudry D, Pamantung TF, Basille M et al (2002) PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci 15:1451–1460
Vaudry D, Hamelink C, Damadzic R, Eskay RL, Gonzalez B, Eiden LE (2005) Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult. Peptides 26:2518–2524
Vaudry D, Falluel-Morel A, Bourgault A et al (2009) Pituitary adenylate cyclase activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283–357
Vossmerbaeumer U, Ohnesorge S, Kuehl S et al (2009) Retinal pigment epithelial phenotype induced in human adipose tissue-derived mesenchymal stromal cells. Cytotherapy 11:177–188
Yoshiyama M, de Groat WC (2008) The role of vasoactive intestinal polypeptide and pituitary adenylate cyclase activating polypeptide in the neural pathways controlling the lower urinary tract. J Mol Neurosci 36:227–240
Zhang XY, Hayasaka S, Chi ZL, Cui HS, Hayasaka Y (2005) Effect of pituitary adenylate cyclase activating polypeptide (PACAP) on IL-6, and MCP-1 expression in human retinal pigment epithelial cell line. Curr Eye Res 30:1105–1111
Acknowledgements
This work was supported by the Hungarian Science Research Fund OTKA K72592, F67830, CNK78480, ETT278-04/2009, Bolyai Scholarship, University of Pecs Medical School Research Grant 2009, Richter Gedeon Foundation, “Science, Please! Research Teams on Innovation” program (SROP-4.2.2/08/1/2008-0011).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mester, L., Kovacs, K., Racz, B. et al. Pituitary Adenylate Cyclase-Activating Polypeptide is Protective Against Oxidative Stress in Human Retinal Pigment Epithelial Cells. J Mol Neurosci 43, 35–43 (2011). https://doi.org/10.1007/s12031-010-9427-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-010-9427-9